Edition:
United States

Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

26.05USD
25 Jul 2016
Change (% chg)

-- (--)
Prev Close
$26.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
633,885
52-wk High
$43.63
52-wk Low
$23.85

ACOR.O

Chart for ACOR.O

About

Acorda Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in the identification, development and commercialization of therapies that restore function and recovers the lives of people with neurological disorders. Its commercial products include Ampyra, Fampyra, Zanaflex Capsules and a generic version of the... (more)

Overall

Beta: 1.46
Market Cap(Mil.): $1,200.05
Shares Outstanding(Mil.): 46.07
Dividend: --
Yield (%): --

Financials

  ACOR.O Industry Sector
P/E (TTM): 83.89 41.28 37.71
EPS (TTM): 0.31 -- --
ROI: 1.31 -9.20 14.43
ROE: 2.21 -9.24 15.61

BRIEF-Acorda presents phase 1 data on Migraine drug at 58th annual meeting of American Headache Society

* There were no serious adverse events, dose limiting toxicities, study discontinuations due to adverse events reported for cvt-427

Jun 09 2016

BRIEF-Biotie Therapies: final results of subsequent offer period of Acorda's tender offer

* Final results of the subsequent offer period of Acorda's tender offer for all securities in Biotie

May 02 2016

BRIEF-Acorda announces results from mid-phase clinical trial of CVT-301

* Acorda Announces Results From Phase 2b Clinical Trial Of CVT 301 for treatment of off periods in parkinson's disease published in movement disorders

Apr 20 2016

BRIEF-Acorda Therapeutics: results of tender offer for Biotie Therapies

* Says tender offer for Biotie Therapies Corp expired on April 8

Apr 13 2016

BRIEF-Biotie Therapies U.S. antitrust regulation relating to tender offer expires

* U.S. antitrust regulation waiting period relating to tender offer has expired

Feb 17 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.